Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Warren

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
The British Journal of Dermatology|March 1, 2013
Treatment of severe psoriasis with biological therapies in patients with viral hepatitis B and CR B Warren, A Al-Rifai, A Al-Ri Fai
The British Journal of Dermatology|April 23, 2014
Safety of biological therapies for psoriasis: effects on reproductive potential and outcomes in male and female patientsZ Z N Yiu, C E M Griffiths, R B Warren
Journal of the European Academy of Dermatology and Venereology : JEADV|December 1, 2019
Long-term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic diseaseK Reich, R B Warren, L C Coates, et al.
The British Journal of Dermatology|February 10, 2019
Long-term, real-world efficacy of biologics for psoriasis: a single centre's experienceL Mercieca, D Lavery, R B Warren, et al.
The British Journal of Dermatology|August 19, 2010
Adalimumab for psoriasis: practical experience in a U.K. tertiary referral centreR B Warren, B C Brown, D Lavery, et al.
Thorax|June 1, 1980
Acquired double-barrel oesophagus in epidermolysis bullosa dystrophicaR B Warren, T F Warner, E F Gilbert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 15, 2020
Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE-2 and -3R B Warren, J B Hansen, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2020
The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasisA Egeberg, P Gisondi, J M Carrascosa, et al.
Clinical and Experimental Dermatology|September 20, 2008
Methotrexate for psoriasis in the era of biological therapyR B Warren, R J G Chalmers, C E M Griffiths, et al.
Clinical and Experimental Dermatology|January 6, 2009
Long-term control of recalcitrant psoriasis with combination infliximab and methotrexateR B Warren, B C Brown, A J Carmichael, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
The British Journal of Dermatology|March 1, 2013
Treatment of severe psoriasis with biological therapies in patients with viral hepatitis B and CR B Warren, A Al-Rifai, A Al-Ri Fai
The British Journal of Dermatology|April 23, 2014
Safety of biological therapies for psoriasis: effects on reproductive potential and outcomes in male and female patientsZ Z N Yiu, C E M Griffiths, R B Warren
Journal of the European Academy of Dermatology and Venereology : JEADV|December 1, 2019
Long-term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic diseaseK Reich, R B Warren, L C Coates, et al.
The British Journal of Dermatology|February 10, 2019
Long-term, real-world efficacy of biologics for psoriasis: a single centre's experienceL Mercieca, D Lavery, R B Warren, et al.
The British Journal of Dermatology|August 19, 2010
Adalimumab for psoriasis: practical experience in a U.K. tertiary referral centreR B Warren, B C Brown, D Lavery, et al.
Thorax|June 1, 1980
Acquired double-barrel oesophagus in epidermolysis bullosa dystrophicaR B Warren, T F Warner, E F Gilbert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 15, 2020
Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE-2 and -3R B Warren, J B Hansen, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2020
The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasisA Egeberg, P Gisondi, J M Carrascosa, et al.
Clinical and Experimental Dermatology|September 20, 2008
Methotrexate for psoriasis in the era of biological therapyR B Warren, R J G Chalmers, C E M Griffiths, et al.
Clinical and Experimental Dermatology|January 6, 2009
Long-term control of recalcitrant psoriasis with combination infliximab and methotrexateR B Warren, B C Brown, A J Carmichael, et al.
Pageof 12